OPTIMIZATION OF RECOMBINANT ANTIBODY PRODUCTION IN CHO CELLS

Recombinant antibody production leverages Chinese hamster ovary (CHO) cells due to their adaptability in expressing complex proteins. Optimizing these processes involves modifying various factors, including cell line development, media formulation, and bioreactor settings. A key goal is to amplify antibody yield while lowering production expenses a